image
By Asia Education Review Team , Friday, 03 May 2024

Ora, SERI announce landmark Partnership in Global Ophthalmic Innovation

  • Ora, Inc., a leading global contract research organization (CRO) in ophthalmology, has announced an exclusive strategic partnership with the Singapore Eye Research Institute (SERI), renowned for its pioneering work in eye research and preclinical studies. This collaboration signifies a groundbreaking advancement in ophthalmology research, merging Ora's extensive clinical development expertise with SERI's cutting-edge preclinical capabilities.

    The partnership aims to provide comprehensive research support to early-stage innovators worldwide, revolutionizing the development of new ophthalmic therapies. SERI specializes in non-clinical ophthalmic animal studies, employing translatable ocular animal models across various species to evaluate drug and device therapies for eye diseases. Known for its scientific rigor and ethical preclinical operations, SERI will collaborate with Ora's clients to expedite the development of therapeutic candidates in ocular-specific therapeutic areas.

    With a focus on precision and thoroughness, SERI offers a range of non-GLP systemic safety, toxicity, ocular safety, pharmacokinetic, pharmacodynamic, and efficacy models for both anterior and posterior segments of the eye. This diverse selection ensures that Ora's clients have access to tailored preclinical evaluation models to meet their specific research needs.  

    Stuart Abelson, Chairman and CEO of Ora, Inc., lauds SERI's stellar reputation and proficiency in preclinical studies, which align seamlessly with Ora's mission. Abelson expresses confidence that by leveraging their combined strengths, they will accelerate the development of innovative therapies across all stages, further solidifying SERI's position as a global center of excellence in ophthalmology research.

    The collaboration marks a new era of preclinical excellence, poised to address the forefront of ophthalmic innovation. Through this partnership, Ora and SERI aim to advance the understanding and treatment of eye diseases, ultimately improving patient outcomes and advancing the field of ophthalmology.